Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma.
Rees MJ, Mammadzadeh A, Bolarinwa A, Elhaj ME, Bohra A, Bansal R, Ailawadhi S, Parrondo R, Chhabra S, Khot A, Hayman S, Dispenzieri A, Buadi F, Dingli D, Warsame R, Kapoor P, Gertz MA, Muchtar E, Kourelis T, Gonsalves W, Rajkumar SV, Lin Y, Kumar S.
Rees MJ, et al.
Blood Cancer J. 2024 Jul 23;14(1):122. doi: 10.1038/s41408-024-01081-z.
Blood Cancer J. 2024.
PMID: 39043638
Free PMC article.